ArticleMarine drugs2021
Biochemical Characterization of
Article in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 31 citations in OpenAlex.
- The Westernmost Record of the Scyphomedusa Cassiopea andromeda (Forskål, 1775) in the Mediterranean: Marine Citizen Science Contributions to Invasive Species Detection and Monitoring.Environmental management · 2025Article
- Global Warming and the Spread of the Introduced Jellyfish Cassiopea andromeda: Thermal Niche and Habitat Suitability in the Mediterranean Sea.Global change biology · 2025Article
- Chemical Defenses in Medusozoa.Marine drugs · 2025Review
- Recent Advancements in Marine Collagen: Exploring New Sources, Processing Approaches, and Nutritional Applications.Marine drugs · 2025Review
- Photobiota of the Tropical Red Sea: Fatty Acid Profile Analysis and Nutritional Quality Assessments.Molecules (Basel, Switzerland) · 2025Article
- Wild or Reared?Marine drugs · 2025Article
- Homosalate and ERK Knockdown in the Modulation ofCurrent issues in molecular biology · 2024Article
- Photophysiological and Oxidative Responses of the Symbiotic Estuarine AnemoneAntioxidants (Basel, Switzerland) · 2024Article
- The Zooxanthellate Jellyfish HolobiontMarine drugs · 2023Article
- Jellyfishes-Significant Marine Resources with Potential in the Wound-Healing Process: A Review.Marine drugs · 2023Review
- Combination of Solid State and Submerged Fermentation Strategies to Produce a New Jellyfish-Based Food.Foods (Basel, Switzerland) · 2022Article
- Chasing Chances in a Changing Sea.Marine drugs · 2022Article
- Jellyfish from Fisheries By-Catches as a Sustainable Source of High-Value Compounds with Biotechnological Applications.Marine drugs · 2022Review
- Jellyfish Bioprospecting in the Mediterranean Sea: Antioxidant and Lysozyme-Like Activities fromMarine drugs · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 7 institutions in 2 countries.
Funding
Abstract
Increasing frequency of native jellyfish proliferations and massive appearance of non-indigenous jellyfish species recently concur to impact Mediterranean coastal ecosystems and human activities at sea. Nonetheless, jellyfish biomass may represent an exploitable novel resource to coastal communities, with reference to its potential use in the pharmaceutical, nutritional, and nutraceutical Blue Growth sectors. The zooxanthellate jellyfish
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.